Business context and reporting period
Onto Innovation designs and supplies process-control systems, software, parts and services for semiconductor and advanced-packaging manufacturers. The filing covers the three months ended April 2, 2022—not 2020 Q1 as specified in the request metadata. Comparative quarter: March 27, 2021. Dollar amounts below are in millions unless stated otherwise.
Financial performance and liquidity
| Metric | Q1 2022 | Q1 2021 |
|---|---|---|
| Revenue | $241.4 | $169.3 |
| Gross profit / margin | $131.0 / 54.3% | $90.5 / 53.4% |
| Operating income / margin | $58.7 / 24.3% | $27.5 / 16.2% |
| Net income / net margin | $53.3 / 22.1% | $24.1 / 14.2% |
| Diluted EPS | $1.07 | $0.49 |
| Operating cash flow | $45.5 | $51.0 |
| Capital expenditures | $2.5 | $3.9 |
Revenue rose 42.6% year over year and 7.0% sequentially. Cash, cash equivalents and marketable securities totaled $541.9 million at quarter-end, versus $511.3 million at January 1, 2022; working capital was $847.6 million. Cash from operations declined year over year, primarily reflecting a $25.4 million use of cash from changes in operating assets and liabilities, including higher inventory and receivables.
Total assets were $1,722.4 million and total liabilities $250.1 million at April 2, 2022. No borrowings are shown on the balance sheet. An unused, securities-secured credit line provided approximately $128.7 million of availability at a stated 2.0% interest rate.
Material changes and business drivers
- Year-over-year revenue growth was mainly driven by higher systems and software sales, particularly increased shipments in metrology and inspection; a larger installed base also supported parts and services.
- Systems and software provided 87% of revenue, compared with 84% a year earlier. China, South Korea and Taiwan together represented most sales; SK Hynix accounted for 19%, TSMC 16% and Samsung Semiconductor 10% of revenue.
- Gross margin improved year over year with higher volume and favorable product mix, partly offset by increased freight, logistics and personnel costs. Sequentially, margin declined from 55% to 54%, primarily due to freight and logistics costs.
- Research and development expense increased to $26.3 million from $22.0 million, primarily from headcount, compensation and new-product development costs. Total operating expenses increased to $72.3 million from $63.0 million.
Outlook, commentary and risks
The filing provides no specific revenue or earnings guidance. Management said first-quarter demand was consistent with or above expectations and expected existing cash, securities and credit availability to meet anticipated needs for the next 12 months. It cited semiconductor-component shortages, strained logistics and higher costs as constraints; it had not experienced a material adverse operational impact from COVID-19 at the time of filing.
- Supply-chain delays, component shortages, inflation and freight costs could constrain shipments, increase inventory needs and pressure margins.
- Revenue is concentrated among a small number of semiconductor customers, and results are exposed to industry cyclicality, long sales cycles and order timing.
- China-related export controls, tariffs, geopolitical developments and foreign-currency movements could affect sales and operations. The company reported no material impact to date from the Russia-Ukraine conflict.
- U.S. tax rules effective in 2022 require research and development costs to be capitalized and amortized over five years, affecting cash flows; potential legislative changes were uncertain.
- A pending customer-related legal matter was in discovery; management assessed the loss contingency as remote and did not expect a material impact. An Inspectrology earnout of up to $5.0 million remained possible; $1.9 million was accrued at quarter-end.
- Marketable securities had $3.5 million of gross unrealized losses at quarter-end. The company reported these as available-for-sale investments.
Important facts to verify
- Confirm the intended reporting period: the supplied filing is Q1 2022, despite request metadata identifying 2020 Q1.
- Review the composition and recoverability of marketable securities and the effects of unrealized losses.
- Track supply-chain constraints, freight and other cost inflation, inventory growth, and their effects on shipments and margins.
- Assess revenue concentration and exposure to China export controls and other international risks.
- Reconcile the filing’s share-repurchase disclosures: it says no repurchases under the authorization, while separately reporting 60,000 shares withheld for equity-award tax settlements.